Lexaria Bioscience (LEXX) Stock: Buy, Sell, or Hold?
LEXX - Lexaria Bioscience Corp. Common Stock
$3.30
0.08 (2.48%)
â˛
5d:
+17.02%
30d:
+5.43%
90d:
+732.7%
WAIT
LOW Confidence
Analysis Updated: Oct 28, 2026 12:00 AM ET
Earnings: Nov 25, 2026
26d
Get Alerted When LEXX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LEXX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LEXX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LEXX is currently trading at $3.30, which is considered slightly high relative to its 30-day fair value range of $2.85 to $3.32.
Technical Outlook: Technically, LEXX is in a uptrend. Immediate support is located at $2.43, while resistance sits at $3.55.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $82.50 (+2400.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LEXX is in a uptrend. Immediate support is located at $2.43, while resistance sits at $3.55.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $82.50 (+2400.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.85 -
$3.32
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2400.0% below Wall St target ($82.50)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.85 -
$3.32
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$2.43
Resistance Level
$3.55
Current Trend
Uptrend
Technical data as of
Oct 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.71
Wall Street Target
$82.50
(+2400.0%)
Revenue Growth (YoY)
-88.5%
Share & Embed Analysis
Last updated: October 28, 2026 10:58 PM ET
Data refreshes hourly during market hours. Next update: 11:58 PM
Data refreshes hourly during market hours. Next update: 11:58 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEXX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
28 analysts |
$92 | 64 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$280 | 51 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
23 analysts |
$108 | 46 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$130 | 57 HOLD |
